全球移民潜伏性结核感染治疗启动与完成情况:系统综述与荟萃分析
汇总显示启动治疗的真实比例为69%(95%CI 51-84),启动后完成治疗为74%(95%CI 66-81),全程完成仅52%(95%CI 40-64)。2010-2020年数据提示治疗启动与完成情况改善,但全程脱失仍显著。
要点
- 移民LTBI阳性者启动治疗的真实比例仅69%,全程完成治疗者仅52%。
- 2010-2020年报告的LTBI项目启动与完成率优于更早数据。
- 需针对移民独特障碍加强临床参与以提升全程完成率。
核心结论
- 移民LTBI治疗启动与完成在2010-2020年显著改善,但全程脱失仍存在,需进一步加强项目以达成低发病率国家结核消除目标。
主要发现
- 荟萃回归显示2010-2020年报告的数据与更好的治疗启动和完成率相关,多种复杂因素影响移民治疗结局。
临床怎么用
- 临床应关注移民LTBI治疗全程脱失,尤其在启动后至完成阶段加强随访与支持。
- 针对移民独特障碍设计干预,提升临床参与度和治疗完成率。
局限性
- 纳入研究异质性极高(I2均>98%),且并非所有文章报告从启动到完成的完整路径数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Latent tuberculosis infection (LTBI) is one of the most prevalent infections globally and can lead to the development of active tuberculosis disease. In many low-burden countries, LTBI is concentrated within migrant populations often because of a higher disease burden in the migrant's country of origin. National programmes consequently focus on screening and treating LTBI in migrants to prevent future tuberculosis cases; however, how effective these programmes are is unclear. We aimed to assess LTBI treatment initiation and outcomes among migrants, and the factors that influence both. METHODS: For this systematic review and meta-analysis, we searched Embase, MEDLINE, and Global Health, and manually searched grey literature from Jan 1, 2000, to April 21, 2020. We included primary research articles reporting on LTBI treatment initiation or completion, or both, in migrants and excluded articles in which data were not stratified by migrant status, or in which the data were related to outcomes before 2000. There were no geographical or language restrictions. All included studies were quality appraised using recognised tools depending on their design, and we assessed the heterogeneity of analyses using I2. We extracted data on the numbers of migrants initiating and completing treatment. Our primary outcomes were LTBI treatment initiation and completion in migrants (defined as foreign-born). We used random-effects meta-regression to examine the influence of factors related to these outcomes. The study is registered with PROSPERO (CRD42019140338). FINDINGS: 2199 publications were retrieved screened, after which 39 publications from 13 mostly high-income, low-burden countries were included in our analyses, with treatment initiation and completion data reported for 31 598 migrants positive for LTBI, with not all articles reporting the full pathway from initiation to completion. The pooled estimate for the true proportion of migrants testing positive who initiated treatment was 69% (95% CI 51-84; I2= 99·62%; 4409 of 8764). The pooled estimate for the true proportion of migrants on treatment in datasets, who subsequently completed it was 74% (95% CI = 66-81; I2= 99·19%; 15 516 of 25 629). Where data were provided for the entire treatment pathway, the pooled estimate for the true proportion of migrants who initiated and completed treatment after a positive test was only 52% (95% CI 40-64; I2= 98·90%; 3289 of 6652). Meta-regression showed that LTBI programmes are improving, with more recent reported data (2010-20) associated with better rates of treatment initiation and completion, with multiple complex factors affecting treatment outcomes in migrants. INTERPRETATION: Although our analysis highlights that LTBI treatment initiation and completion in migrants has improved considerably from 2010-20, there is still room for improvement, with drop out reported along the entire treatment pathway. The delivery of these screening and treatment programmes will require further strengthening if the targets to eradicate tuberculosis in low-incidence countries are to be met, with greater focus needed on engaging migrants more effectively in the clinic and understanding the diverse and unique barriers and facilitators to migrants initiating and completing treatment. FUNDING: European Society of Clinical Microbiology and Infectious Diseases, the Rosetrees Trust, the National Institute for Health Research, and the Academy of Medical Sciences.
引用
- Rustage K, Lobe J, Hayward SE, et al. Initiation and completion of treatment for latent tuberculosis infection in migrants globally: a systematic review and meta-analysis. Lancet Infect Dis. 2021. PMID: 34363771. doi:10.1016/S1473-3099(21)00052-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。